Literature DB >> 23036027

A prospective analysis of the preoperative assessment of duodenal involvement in gallbladder cancer.

Raja Kalayarasan1, Amit Javed, Amarender S Puri, Sunil K Puri, Puja Sakhuja, Anil K Agarwal.   

Abstract

BACKGROUND: Duodenal involvement occurs frequently in gallbladder cancer (GBC) as a result of the proximity of the duodenum to the gallbladder.
METHODS: The study group included 74 GBC patients assessed between August 2009 and March 2011 in whom computed tomography (CT) of the abdomen indicated suspicion for duodenal involvement.
RESULTS: Of 172 patients with resectable GBC, 74 (43.0%) had suspected duodenal involvement on imaging. Of these, 51 (68.9%) had suspected duodenal involvement on upper gastrointestinal endoscopy (UGIE). Symptoms of gastric outlet obstruction (GOO) were present in only 14 (18.9%) patients. Thirteen (17.6%) patients underwent staging laparoscopy alone. Of the 61 patients who underwent laparotomy, 31 (50.8%) were found to have actual duodenal involvement. The positive predictive value (PPV) of CT of the abdomen for duodenal involvement was 50.8% (31 of 61 patients). The addition of UGIE increased the PPV to 65.9% (27 of 41 patients). In the subgroup with evidence of duodenal mural thickening or mucosal irregularity on CT of the abdomen (n= 9) or duodenal mucosal infiltration on UGIE (n= 14), the PPV increased to 100%. A total of 33 (44.6%) patients underwent curative resection. The resectability rate was significantly lower in patients with symptoms of GOO [two of 14 (14.3%) vs. 31 of 60 (51.7%); P= 0.010], CT findings of duodenal mural thickening or mucosal irregularity compared with only loss of the fat plane [two of 12 (16.7%) vs. 31 of 62 (50.0%); P= 0.032], and UGIE evidence of duodenal infiltration compared with extrinsic compression or normal endoscopic findings [three of 16 (18.8%) vs. 18 of 35 (51.4%) and 12 of 23 (52.2%), respectively; P= 0.027 and P= 0.036, respectively].
CONCLUSIONS: Overall, CT of the abdomen demonstrated a PPV of 50.8% in detecting duodenal involvement, which increased to 65.9% with the addition of UGIE. The combined presence of GOO symptoms, CT findings of duodenal mural thickening and mucosal irregularity, and UGIE findings of infiltration of the duodenal mucosa significantly decreases resectability but does not preclude resection.
© 2012 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2012        PMID: 23036027      PMCID: PMC3572281          DOI: 10.1111/j.1477-2574.2012.00539.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  18 in total

1.  Feasibility of en-bloc wedge resection of the pancreas and/or the duodenum as an alternative to pancreatoduodenectomy for advanced gallbladder cancer.

Authors:  Satoshi Hirano; Eiichi Tanaka; Toshiaki Shichinohe; Katsunori Saitoh; Mikiya Takeuchi; Naoto Senmaru; On Suzuki; Satoshi Kondo
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-03-27

2.  Extensive surgery for carcinoma of the gallbladder.

Authors:  S Kondo; Y Nimura; N Hayakawa; J Kamiya; M Nagino; K Uesaka
Journal:  Br J Surg       Date:  2002-02       Impact factor: 6.939

3.  Spread of gallbladder carcinoma: CT evaluation with pathologic correlation.

Authors:  T Ohtani; Y Shirai; K Tsukada; T Muto; K Hatakeyama
Journal:  Abdom Imaging       Date:  1996 May-Jun

4.  Strategies for surgical treatment of gallbladder carcinoma based on information available before resection.

Authors:  Norihiro Kokudo; Masatoshi Makuuchi; Takeshi Natori; Yoshihiro Sakamoto; Junji Yamamoto; Makoto Seki; Tamaki Noie; Yasuhiko Sugawara; Hiroshi Imamura; Shingo Asahara; Takaaki Ikari
Journal:  Arch Surg       Date:  2003-07

5.  Helical CT of the local spread of carcinoma of the gallbladder: evaluation according to the TNM system in patients who underwent surgical resection.

Authors:  Kengo Yoshimitsu; Hiroshi Honda; Kenji Shinozaki; Hitoshi Aibe; Toshiro Kuroiwa; Hiroyuki Irie; Kazuo Chijiiwa; Yoshiki Asayama; Kouji Masuda
Journal:  AJR Am J Roentgenol       Date:  2002-08       Impact factor: 3.959

6.  Major hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancer.

Authors:  Michael D'Angelica; Robert C G Martin; William R Jarnagin; Yuman Fong; Ronald P DeMatteo; Leslie H Blumgart
Journal:  J Am Coll Surg       Date:  2004-04       Impact factor: 6.113

7.  Accuracy of preoperative T-staging of gallbladder carcinoma using MDCT.

Authors:  Soo Jin Kim; Jeong Min Lee; Jae Young Lee; Jin Young Choi; Se Hyung Kim; Joon Koo Han; Byung Ihn Choi
Journal:  AJR Am J Roentgenol       Date:  2008-01       Impact factor: 3.959

8.  Radical operations for carcinoma of the gallbladder: present status in Japan.

Authors:  Y Ogura; R Mizumoto; S Isaji; T Kusuda; S Matsuda; M Tabata
Journal:  World J Surg       Date:  1991 May-Jun       Impact factor: 3.352

9.  Aggressive surgical approach for stage IV gallbladder carcinoma based on Japanese Society of Biliary Surgery classification.

Authors:  Hiroaki Shimizu; Fumio Kimura; Hiroyuki Yoshidome; Masayuki Ohtsuka; Atsushi Kato; Hideaki Yoshitomi; Satoshi Nozawa; Katunori Furukawa; Noboru Mitsuhashi; Dan Takeuchi; Kosuke Suda; Isaku Yoshioka; Masaru Miyazaki
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-07-30

Review 10.  Carcinoma of the gall-bladder: an experience and review of the literature.

Authors:  D S Wilkinson
Journal:  Aust N Z J Surg       Date:  1995-10
View more
  3 in total

1.  Role of routine 16b1 lymph node biopsy in the management of gallbladder cancer: an analysis.

Authors:  Anil K Agarwal; Raja Kalayarasan; Amit Javed; Puja Sakhuja
Journal:  HPB (Oxford)       Date:  2013-07-22       Impact factor: 3.647

2.  Gallbladder cancer: expert consensus statement.

Authors:  Thomas A Aloia; Nicolas Járufe; Milind Javle; Shishir K Maithel; Juan C Roa; Volkan Adsay; Felipe J F Coimbra; William R Jarnagin
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

3.  Mass-forming xanthogranulomatous cholecystitis masquerading as gallbladder cancer.

Authors:  Anil Kumar Agarwal; Raja Kalayarasan; Amit Javed; Puja Sakhuja
Journal:  J Gastrointest Surg       Date:  2013-04-25       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.